FDA Alert
FDA Alert
04/22/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA previously approved lisocabtagene maraleucel as a second-line treatment option for adult patients with large B-cell lymphoma in June 2022.
04/22/2024
FDA ALERT
FDA ALERT
01/26/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved pirtobrutinib for adults with either chronic lymphocytic leukemia or small lymphocytic lymphoma who have received at least two prior lines of therapy.
01/26/2024
Lymphoma
Lymphoma
06/23/2017
The US Food and Drug Administration has approved a combination intravenous treatment for follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia.
06/23/2017
Hodgkin Lymphoma
Hodgkin Lymphoma
05/16/2017
The FDA has posted a correction for this press release: "The notice posted to the Hematology/Oncology Approvals web page yesterday afternoon regarding an approval for the treatment of Hodgkin lymphoma...
05/16/2017
Lymphoma
Lymphoma
07/07/2014